Therefore, while insulin therapy continues to remain the core of the therapeutic approach in diabetes, ACC dysregulation due to glycemic stress or unwanted side effects of insulin abundance should be resolved for optimal outcomes. This evidence concerns the gene INS and diabetes mellitus.